Paradigm Biopharmaceuticals Health Care
Biotech Healthcare

$0.990 0.060 (6.45%)

High $1.02	Low $0.93	Trades 390	Turnover $1,053,513	Volume 1,077,429
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code PAR	Name Paradigm Biopharmaceuticals Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 599,189,904	Shares Floated 411,566,957	Held by Insiders 10.119%	Held by Institutions 6.821%

Directors & Officers

Name & Education	Position
Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC	Founder, MD & Executive Chairman
Dr. Donna L. Skerrett M.D., MS	Chief Medical Officer
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.	Company Secretary & CFO
Dr. Ravi Krishnan	Chief Scientific Officer
Mr. Simon White	Director of Investor Relations
Dr. Michael Imperiale	Global Head of Drug Safety & MPS
Ms. Beverley Huttmann	Commercial Head
Dr. Mukesh Ahuja	Global Clinical Head of OA

PAR Historic Dividends

Date	Amount
We found no dividends on record for PAR.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$0.17	873,561	+0.01 (3.13%)
30-Jul	$0.16	1,466,351	-0.01 (3.03%)
29-Jul	$0.17	2,026,994	0.00 (0.00%)
28-Jul	$0.17	613,971	-0.01 (2.94%)
27-Jul	$0.17	999,531	+0.01 (3.03%)
24-Jul	$0.17	1,775,603	-0.01 (5.71%)
23-Jul	$0.18	803,547	0.00 (0.00%)
22-Jul	$0.18	989,010	+0.01 (6.06%)
21-Jul	$0.17	1,168,559	0.00 (0.00%)
20-Jul	$0.17	1,010,250	-0.01 (2.94%)
17-Jul	$0.17	945,897	-0.11 (39.29%)
18-Sep	$0.28	933,171	+0.01 (3.70%)
12-Sep	$0.27	1,305,615	+0.01 (1.89%)
11-Sep	$0.27	722,668	-0.02 (5.36%)
05-Sep	$0.28	725,716	+0.02 (5.66%)
6 up, 6 down, and 3 flat days

Market Cap (31-Jul) $98,006,832	EBITDA -	PE 8.12	Book Value $0.01
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.10	Profit Margin N/A
Operating Margin -86793.89%	ROA 82.94%	ROE 180.22%	Revenue (FY) $8,450
Revenue per Share -	Gross Profit (FY) $2,073	Q' YOY Revenue Growth 50.6%	Q' YOY Earnings Growth -

Paradigm Biopharmaceuticals Health Care
Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

PAR Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Paradigm Biopharmaceuticals Health Care Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

PAR Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Paradigm Biopharmaceuticals Health Care
Biotech Healthcare